热门资讯> 正文
HUT,CXAI和BDRX在市场前的输家中
2024-04-02 20:37
- Losers: Acorda Therapeutics (ACOR) -76% as it files for Chapter 11 bankruptcy.
- Gritstone Bio (GRTS) -43% on prices $32.5M equity offering.
- Verve Therapeutics (VERV) -36% after pausing trial enrollments for lead asset.
- Canoo (GOEV) -29% reports mixed Q4 results.
- PVH Corp (PVH) -23% after Q4 earnings release.
- Avalo Therapeutics (AVTX) -20% appoints Biotech leaders to board of directors.
- Pioneer Power Solutions (PPSI) -19% after Q4 earnings release.
- Petros Pharmaceuticals (PTPI) -19%.
- Imuno (IMNN) -13%.
- CXApp (CXAI) -14%.
- Terran Orbital Corp (LLAP) -12% after Q4 earnings release.
- Xilio Therapeutics (XLO) -12% reports Q4 results.
- AST SpaceMobile (ASTS) -11% after FY earnings release.
- Humana (HUM) -10%.
- Biodexa Pharmaceuticals Plc (BDRX) -10%.
- Hut 8 Corp (HUT) -9%.
- iBio (IBIO) -9%.
- Allego NV (ALLG) -9% to postpone fourth quarter and full year 2023 financial results conference call.
- Ocugen (OCGN) -8% provides business update with certain financials for the year ending 2023.
- Petco Health and Wellness Co (WOOF) -8% after double downgrade from BofA.
- Griid Infrastructure (OTCPK:GRDI) -7%.
- Lytus Technologies Holdings PTV Ltd (LYT) -8%.
- Cipher Mining (CIFR) -7% bitcoin production slips 5% M/M in March.
- Microstrategy (MSTR) -7%.
- Argo Blockchain Plc (ARBK) -7%.
More on Pre-market losers & stocks.
- Hut 8 Mining Corp. (HUT) Q4 2023 Earnings Call Transcript
- From Bull To Bear: Recent Events Drove Me To Exit My Position In HUT 8
- Hut 8 Post-Merger Comprehensive Thesis: JCapital Research Might Be Right
- Hut 8 stock jumps 14% after six-month results turn a profit
- Hut 8 GAAP EPS of $0.11, revenue of $60.61M
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。